Zelira Therapeutics Limited (ZLDAF)
OTCMKTS · Delayed Price · Currency is USD
0.2998
+0.0125 (4.35%)
At close: Mar 13, 2025

Zelira Therapeutics Revenue

Zelira Therapeutics had revenue of 655.00 AUD in the half year ending December 31, 2024, a decrease of -99.15%. This brings the company's revenue in the last twelve months to 40.88K, down -85.34% year-over-year. In the fiscal year ending June 30, 2024, Zelira Therapeutics had annual revenue of 94.95K, down -68.47%.

Revenue (ttm)
40.88K AUD
Revenue Growth
-85.34%
P/S Ratio
114.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.90M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 202494.95K-206.17K-68.47%
Jun 30, 2023301.12K-1.24M-80.45%
Jun 30, 20221.54M877.31K132.26%
Jun 30, 2021663.32K--
Jun 30, 2020---
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro